Key TakeawaysA $2 billion fund’s latest 13F shows its three biggest adds in the quarter ended June 30 were Viridian Therapeutics, Travere Therapeutics, and Legend Biotech. Analysts’ average price ...
Support is available after your IgA nephropathy diagnosis. These IgAN resources offer information, financial assistance, community, and updates on new treatments.
The F/m Emerald Life Sciences Innovation ETF (LFSC) ranks in the 12th percentile of Morningstar’s US Fund Health category, measured against 154 funds over the ...
Mini futures (ESZ26) are up +0.57%, and December Nasdaq 100 E-Mini futures (NQZ26) are up +0.86% this morning, signaling a ...
Keenova Therapeutics plc, a leading developer and manufacturer of branded therapeutics, announced today that it will report its third quarter 2026 financial results on Tuesday, November 10, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results